2012
DOI: 10.1002/cld.2
|View full text |Cite
|
Sign up to set email alerts
|

The horizon: New targets and new agents†

Abstract: http://onlinelibrary.wiley.com/journal/10.1002/%28ISSN%292046-2484/homepage/muir.htm the interview with the authors http://onlinelibrary.wiley.com/journal/10.1002/%28ISSN%292046-2484/homepage/muir_reading.htm the video presentation of this article https://wileyhealthlearning.com/Activity/993239/Activity.aspx

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
1

Year Published

2017
2017
2017
2017

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 99 publications
0
0
1
Order By: Relevance
“…However, there was no other documented HCV transmission in the cohort. The recent approval of direct‐acting agents, well tolerated, safe and highly effective, to treat HCV infections may modify the post‐transplant outcome of the recipients who received organs from anti‐HCV/HCV‐RNA‐positive donors and policies regarding the use of organs from HCV donors should be reconsidered .…”
Section: Discussioncontrasting
confidence: 44%
“…However, there was no other documented HCV transmission in the cohort. The recent approval of direct‐acting agents, well tolerated, safe and highly effective, to treat HCV infections may modify the post‐transplant outcome of the recipients who received organs from anti‐HCV/HCV‐RNA‐positive donors and policies regarding the use of organs from HCV donors should be reconsidered .…”
Section: Discussioncontrasting
confidence: 44%